[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

August 2017 | 159 pages | ID: N91BF17BC34EN
MarketsandMarkets

US$ 5,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
“Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%”

The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing, the high cost of sequencing infrastructure, the need for skilled professionals for efficient NGS sample preparation and analysis, and technological advancements in the field of sequencing are driving the growth of this market. However, installation of in-house sequencing facilities in hospitals and universities is expected to limit the optimal market growth for NGS services during the forecast period

“Targeted resequencing & custom gene panels are expected to grow at the highest CAGR during 2017 to 2022”

By type, the global NGS services market covers targeted resequencing & custom gene panels, RNA-Seq, de novo sequencing, exome sequencing, CHiP-Seq, whole-genome sequencing, methyl-seq, and other services. The targeted resequencing & custom gene panels segment is expected to grow at the highest CAGR during 2017 to 2022. Targeted sequencing/gene panels allow researchers to focus on the subset of genes or region, which reduces the time consumed for sequencing, the cost of sequencing, and simplifies data analysis.

“Sequencing by synthesis technology to dominate the global NGS services market during the forecast period”

By technology, the NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. The SBS segment is estimated to account for the largest share of the NGS services market in 2017. The introduction of technologically advanced SBS platforms and decreasing cost of sequencing are the major factors driving the growth of the SBS segment.

“APAC is projected to witness the highest growth during the forecast period “

While North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. This is owing to increasing incidence of target diseases, rising awareness regarding the benefits of NGS-based clinical applications, and growing research activity in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:
  • By Company Type - Tier 1 –31%, Tier 2 –48% and Tier 3 –21%
  • By Designation – C level – 26%, Director level – 24%, Others – 50%
  • By Region – North America – 29%, Europe – 35%, APAC – 21%, RoW – 15%
As of 2016, major players operating in the global NGS services market are BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), and GATC Biotech AG (Germany) among others.

RESEARCH COVERAGE

This report studies the NGS services market-based on type, technology, application, and end user. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four main regions.

Reasons to Buy the Report:

This research focuses on various levels of analysis—competitive leadership analysis of 25 market players, and company profiles of top 15 market players—which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS services market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on business strategies adopted by the major players in the NGS services market. The report analyzes the NGS services market-based on types, technology, application, end user, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product & service launches in the NGS services.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS services across geographies.
  • Market Diversification: Exhaustive information about new NGS services, untapped geographies, recent developments, and investments in the NGS services market.
  • Competitive Assessment: In-depth assessment of market ranking, strategies, products and services, and sequencing capabilities of leading players in the NGS services market.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
  1.2.1 MARKETS COVERED
  1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
  2.2.1 SECONDARY RESEARCH
    2.2.1.1 Key data from secondary sources
  2.2.2 PRIMARY DATA
    2.2.2.1 Breakdown of primaries
    2.2.2.2 Key data from primary sources
    2.2.2.3 Key industry insights
2.3 MARKET SIZE ESTIMATION
  2.3.1 BOTTOM-UP APPROACH
  2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET OVERVIEW
4.2 GLOBAL NGS SERVICES MARKET, BY TYPE, 2015 VS. 2017 VS. 2022 (USD MILLION)
4.3 GEOGRAPHIC ANALYSIS: NGS SERVICES MARKET, BY TECHNOLOGY (2017)
4.4 NGS SERVICES MARKET, BY APPLICATION
4.5 GLOBAL NGS SERVICES MARKET, BY END USER, 2017 VS. 2022
4.6 GEOGRAPHICAL SNAPSHOT OF THE NGS SERVICES MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Declining price of sequencing
    5.2.1.2 High cost of sequencing infrastructure
    5.2.1.3 Need for skilled professionals for efficient NGS sample preparation and analysis
    5.2.1.4 Sequencing services, the preferred option for NGS applications with low throughput requirements
    5.2.1.5 Technological advancements in the field of sequencing
  5.2.2 RESTRAINTS
    5.2.2.1 Installation of in-house sequencing facilities in hospitals and universities
  5.2.3 OPPORTUNITIES
    5.2.3.1 Analysis of complex sequencing data
    5.2.3.2 Increasing applications in cancer and agrigenomics research
  5.2.4 CHALLENGES
    5.2.4.1 Accuracy & standardization concerns in diagnostic testing
    5.2.4.2 Ethical issues related to NIPT

6 GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY

6.2 INTRODUCTION
6.3 SEQUENCING BY SYNTHESIS
6.4 ION SEMICONDUCTOR SEQUENCING
6.5 SINGLE-MOLECULE REAL-TIME SEQUENCING
6.6 NANOPORE SEQUENCING

7 GLOBAL NGS SERVICES MARKET, BY SERVICE TYPE

7.1 INTRODUCTION
7.2 TARGETED RESEQUENCING & CUSTOM GENE PANELS
7.3 RNA-SEQ
7.4 DE NOVO SEQUENCING
7.5 EXOME SEQUENCING
7.6 CHIP-SEQ
7.7 WHOLE-GENOME SEQUENCING
7.8 METHYL-SEQ
7.9 OTHER SERVICES

8 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 DIAGNOSTICS
  8.2.1 ONCOLOGY
  8.2.2 INFECTIOUS DISEASES
  8.2.3 RARE GENETIC DISORDERS
  8.2.4 REPRODUCTIVE HEALTH
  8.2.5 OTHER DIAGNOSTIC APPLICATIONS
8.3 DRUG DISCOVERY
8.4 BIOMARKER DISCOVERY
8.5 AGRICULTURE & ANIMAL RESEARCH
8.6 OTHER APPLICATIONS

9 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER

9.1 INTRODUCTION
  9.1.1 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS
  9.1.2 HOSPITALS & CLINICS
  9.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.1.4 OTHER END USERS

10 GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 U.S.
  10.2.2 CANADA
10.3 EUROPE
  10.3.1 GERMANY
  10.3.2 U.K.
  10.3.3 FRANCE
  10.3.4 REST OF EUROPE
10.4 ASIA-PACIFIC
  10.4.1 CHINA
  10.4.2 JAPAN
  10.4.3 INDIA
  10.4.4 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET RANKING ANALYSIS
11.3 COMPETITIVE LEADERSHIP BENCHMARKING
  11.3.1 VISIONARY LEADERS
  11.3.2 INNOVATORS
  11.3.3 DYNAMIC DIFFERENTIATORS
  11.3.4 EMERGING COMPANIES
11.4 STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
11.5 BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS)

*Top 25 companies analyzed for this study are - Illumina, Inc., BGI, Eurofins Scientific SE, PerkinElmer, Inc., QIAGEN N.V., GATC Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Inc., Takara Bio Inc., SciGenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics BioSci & Tech. Co., Ltd., Zymo Research Corp, Source BioScience, IntegraGen SA, CENTOGENE AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.

12 COMPANY PROFILES

12.1 INTRODUCTION
(OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

12.2 BGI
12.3 ILLUMINA, INC.
12.4 PERKINELMER, INC.
12.5 EUROFINS SCIENTIFIC SE
12.6 GATC BIOTECH AG
12.7 MACROGEN, INC.
12.8 QIAGEN N.V.
12.9 GENOTYPIC TECHNOLOGY PVT. LTD.
12.10 GENEWIZ, INC.
12.11 DNA LINK, INC.
12.12 TAKARA BIO INC. (PART OF TAKARA HOLDING COMPANY INC.)
12.13 SCIGENOM LABS PVT. LTD
12.14 NOVOGENE CORPORATION
12.15 PERSONALIS, INC.
12.16 LGC LIMITED (A PART OF KKR & CO. L.P.)

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 NGS SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 2 NGS SERVICES MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2015–2022 (USD MILLION)
TABLE 3 NGS SERVICES MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2015–2022 (USD MILLION)
TABLE 4 NGS SERVICES MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2015–2022 (USD MILLION)
TABLE 5 NGS SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION, 2015–2022 (USD MILLION)
TABLE 6 NGS SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 7 TARGETED SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 8 RNA-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 9 DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 10 EXOME SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 11 CHIP-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 12 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 13 METHYL-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 14 OTHER NGS SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 16 NGS DIAGNOSTIC SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 17 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 18 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DRUG DISCOVERY, BY REGION, 2015–2022 (USD MILLION)
TABLE 19 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2015–2022 (USD MILLION)
TABLE 20 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2015–2022 (USD MILLION)
TABLE 21 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 22 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 23 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 24 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 25 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION)
TABLE 26 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 27 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 28 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 29 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 30 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 31 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 32 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 33 U.S.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 34 CANADA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 35 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 36 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 37 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 38 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 39 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 40 GERMANY: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 41 U.K.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 42 FRANCE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 43 ROE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 44 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 45 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 46 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 47 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 48 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 49 CHINA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 50 JAPAN: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 51 INDIA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 52 ROAPAC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 53 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 54 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
TABLE 55 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 56 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL NGS SERVICES MARKET: RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 NGS SERVICES MARKET: BOTTOM-UP APPROACH
FIGURE 5 NGS SERVICES MARKET: TOP-DOWN APPROACH
FIGURE 6 NGS SERVICES MARKET: DATA TRIANGULATION
FIGURE 7 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2017 VS. 2022
FIGURE 8 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD MILLION)
FIGURE 9 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
FIGURE 10 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE NEXT-GENERATION SEQUENCING SERVICES MARKET
FIGURE 12 INCREASING APPLICATIONS OF NGS IN CANCER AND AGRIGENOMICS RESEARCH TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
FIGURE 13 NORTH AMERICA TO DOMINATE THE NGS SERVICES MARKET IN 2017
FIGURE 14 AGRICULTURE & ANIMAL RESEARCH SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE NGS SERVICES MARKET BETWEEN 2017 & 2022
FIGURE 15 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NGS SERVICES MARKET IN 2022
FIGURE 16 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 17 NEXT-GENERATION SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 HUMAN WHOLE-GENOME SEQUENCING COST ESTIMATED BY THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE
FIGURE 19 NANOPORE SEQUENCING TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2017 TO 2022)
FIGURE 20 NGS SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
FIGURE 21 TARGETED RESEQUENCING/CUSTOM GENE PANELS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET IN 2022
FIGURE 22 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET IN 2022
FIGURE 23 GROWTH IN NUMBER OF GENETIC TESTS (2012–2016)
FIGURE 24 INCREASING PUBLICATIONS RELATED TO BIOMARKER DISCOVERY BASED ON NGS DURING 2011-2016
FIGURE 25 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 26 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION
FIGURE 27 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
FIGURE 28 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
FIGURE 29 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
FIGURE 30 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
FIGURE 31 BGI, EUROFINS SCIENTIFIC SE, AND MACROGEN WERE THE LEADING PROVIDERS FOR NGS SERVICES WORLDWIDE IN 2016
FIGURE 32 NGS SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
FIGURE 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2016)
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
FIGURE 35 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2016)
FIGURE 36 MACROGEN, INC.: COMPANY SNAPSHOT (2015)
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2016)
FIGURE 38 TAKARA BIO INC.: COMPANY SNAPSHOT (2016)


More Publications